From: Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology
N (% isolates) | Carbapenem resistance N (%) | |
---|---|---|
Acinetobacter baumannii | 32 (29.7%) | 27/32 (84.4%) |
Klebsiella pneumoniae | 26 (24.1%) | 6/26 (23.1%) |
Pseudomonas aeruginosa | 24 (22.2%) | 11/24 (45.8%) |
Staphylococcus aureus | 10 (9.3%) | 5* (50%) |
Haemophilus influenza | 5 (4.6%) | 0 (0%) |
Elizabethkingia meningoseptica | 3 (2.8%) | 1 (33.3%) |
Stenotrophomonas maltophilia | 3 (2.8%) | 3 (100%) |
Streptococcus pneumoniae | 3 (2.8%) | 0* (0%) |
Escherichia coli | 1 (0.9%) | 1 (100%) |
Proteus mirabilis | 1 (0.9%) | 0 (0%) |